- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
- Locations
-
- General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece
- Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT05230680
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea
NCT04349358
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- CHU de Besançon Besançon, France
- Centre Georges François Leclerc Dijon, France
- CHU de Dijon Dijon, France
Recruiting
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NCT06084962
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT06081478
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +18 more
- Locations
-
- Liang Wang Beijing, Beijing Municipality, China
NCT04558931
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Karolinska University Hospital, Huddinge Stockholm, Sweden
NCT04758975
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Recruiting
National Registry of Rare Kidney Diseases
NCT06065852
- Conditions
- AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
- Locations
-
- Zoe Plummer Bristol, South West, United Kingdom
Recruiting
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
NCT04908228
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Strategic Research Program on CLL Milan, MI, Italy
NCT06059521
- Conditions
- Astigmatism, Eye Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Airdoc MPC Opthalmology Clinics Beijing, Beijing Municipality, China
- Jenny QIU Beijing, Beijing Municipality, China
- Qiu Jenny Beijing, Haidian District, China